Submission supported by positive results from global, Phase 3 4WHIM clinical trial;U.S. regulatory approval in WHIM syndrome granted in ...

X4 Pharmaceuticals (XFOR) announced that its Marketing Authorization Application for mavorixafor for the treatment of WHIM syndrome, a rare ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

Shares of Recursion Pharmaceuticals Inc climbed 5.6% on Wednesday morning, reaching a three-week high as trading volumes hit ...

The clock is ticking for medical device and pharmaceutical companies to fulfill their obligations under the Physician ...

Nelipak said the ISCC certification reflects the healthcare packaging supplier's commitment to sustainable tackaging and ...

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Trained health care professionals (THCPs), including medical assistants, respiratory therapists, and nurses, with artificial intelligence (AI) assistance can achieve lung ultrasound (LUS) images with ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...